Ms. Jill L. Preis, LCSW,CADC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 7 Weasel Drift Rd, West Paterson, NJ 07424 Phone: 973-925-8989 Fax: 973-742-0175 |
News Archive
BioWorld Today recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.
Teenage boys have feelings, too, and when it comes to matters of the heart, they may not be so fleeting after all. Not far beneath the bravado often on display is an unsure adolescent who finds it hard to express emotions that, while new, are nonetheless often sincerely felt.
Covidien, a leading global provider of healthcare products, today introduced EXALGOâ„¢ (hydromorphone HCI) Extended-Release Tablets, (CII), the only extended-release hydromorphone treatment available in the United States. This proven therapy, combined with an innovative delivery system, provides opioid-tolerant patients suffering from moderate-to-severe chronic pain relief for 24 hours per dose.
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
A genetic variation believed to increase risk for heart failure in people of African or Latino ancestry has been identified in a new study by researchers from the Icahn School of Medicine at Mount Sinai and Perelman School of Medicine at the University of Pennsylvania.
› Verified 8 days ago